"Risperidone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
| Descriptor ID |
D018967
|
| MeSH Number(s) |
D03.383.742.698.685
|
| Concept/Terms |
R-64,766- R-64,766
- R 64,766
- R64,766
- R-64766
- R 64766
- R64766
|
Below are MeSH descriptors whose meaning is more general than "Risperidone".
Below are MeSH descriptors whose meaning is more specific than "Risperidone".
This graph shows the total number of publications written about "Risperidone" by people in this website by year, and whether "Risperidone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 6 | 10 |
| 2018 | 4 | 6 | 10 |
| 2019 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Risperidone" by people in Profiles.
-
The effect of prohibiting outside food during COVID-19 pandemic on the body weight of schizophrenic patients taking olanzapine or clozapine: a retrospective self-controlled study. Ann Palliat Med. 2021 May; 10(5):5010-5016.
-
Abrupt Late-onset Psychosis as a Presentation of Coronavirus 2019 Disease (COVID-19): A Longitudinal Case Report. J Psychiatr Pract. 2021 Mar 05; 27(2):131-136.
-
Brief psychotic disorder associated with quarantine and mild COVID-19. BMJ Case Rep. 2020 Dec 16; 13(12).
-
Acetyl-l-Carnitine and New-Onset Psychosis During the COVID-19 Pandemic. Prim Care Companion CNS Disord. 2020 12 03; 22(6).
-
An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes. J Psychopharmacol. 2019 10; 33(10):1227-1236.
-
Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor. Toxicol Appl Pharmacol. 2019 09 01; 378:114643.
-
Liquid jet breakup: A new method for the preparation of poly lactic-co-glycolic acid microspheres. Eur J Pharm Biopharm. 2019 Apr; 137:140-147.
-
Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia. Fundam Clin Pharmacol. 2019 Jun; 33(3):355-364.
-
Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting. J Child Adolesc Psychopharmacol. 2019 03; 29(2):133-140.
-
Morgellons disease: insights into treatment. Dermatol Online J. 2018 Nov 15; 24(11).